Axon Neuroscience

Axon Neuroscience company information, Employees & Contact Information

AXON Neuroscience is a clinical-stage biotech company founded in 1999 with a specialized team of researchers focused exclusively on tau immunotherapies and tau diagnostic platforms. AXON has identified and wholly owns several compounds which are being investigated as potentially disease-modifying therapies for the treatment of Alzheimer's disease and other tauopathies. The two lead compounds are the active vaccine AADvac1 and the monoclonal antibody AADvac2. The tau vaccine AADvac1 has potential to be the first breakthrough therapy to address Alzheimer's disease and help millions of people suffering from the devastating disease. Axon is also developing a suite of diagnostic assays to more accurately identify patients with potential tau-derived brain diseases that can benefit from its novel therapeutic candidates.

Company Details

Employees
31
Founded
-
Address
Dvořákovo Nábrežie 10, Bratislava,811 02,slovakia
Phone
866.658.3979
Email
of****@****ence.eu
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Bratislava
Looking for a particular Axon Neuroscience employee's phone or email?

Axon Neuroscience Questions

News

Membrane mechanics dictate axonal pearls-on-a-string morphology and function - Nature

Membrane mechanics dictate axonal pearls-on-a-string morphology and function Nature

Myelin–axon interface vulnerability in Alzheimer’s disease revealed by subcellular proteomics and imaging of human and mouse brain - Nature

Myelin–axon interface vulnerability in Alzheimer’s disease revealed by subcellular proteomics and imaging of human and mouse brain Nature

Axon Neuroscience Appoints Michal Fresser as Group CEO - PR Newswire

Axon Neuroscience Appoints Michal Fresser as Group CEO PR Newswire

Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial - The Lancet

Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial The Lancet

Evaluating TRIM46's Role in Axon Initial Segment Formation - Journal of Neuroscience

Evaluating TRIM46's Role in Axon Initial Segment Formation Journal of Neuroscience

The Axon-Myelin Unit in Development and Degenerative Disease - Frontiers

The Axon-Myelin Unit in Development and Degenerative Disease Frontiers

Gruber Neuroscience Prize awarded to three for their work on axon guidance - YaleNews

Gruber Neuroscience Prize awarded to three for their work on axon guidance YaleNews

Introducing the Axon Registry - Neurology® Journals

Introducing the Axon Registry Neurology® Journals

Structural and Functional Plasticity at the Axon Initial Segment - Frontiers

Structural and Functional Plasticity at the Axon Initial Segment Frontiers

Extremely Low Forces Induce Extreme Axon Growth - Journal of Neuroscience

Extremely Low Forces Induce Extreme Axon Growth Journal of Neuroscience

Estimating axon radius using diffusion-relaxation MRI: calibrating a surface-based relaxation model with histology - Frontiers

Estimating axon radius using diffusion-relaxation MRI: calibrating a surface-based relaxation model with histology Frontiers

Programmed axon degeneration: from mouse to mechanism to medicine - Nature

Programmed axon degeneration: from mouse to mechanism to medicine Nature

Nonresolving Neuroinflammation Regulates Axon Regeneration in Chronic Spinal Cord Injury - Journal of Neuroscience

Nonresolving Neuroinflammation Regulates Axon Regeneration in Chronic Spinal Cord Injury Journal of Neuroscience

Intrinsic mechanisms of neuronal axon regeneration - Nature

Intrinsic mechanisms of neuronal axon regeneration Nature

TRIM46 Organizes Microtubule Fasciculation in the Axon Initial Segment - Journal of Neuroscience

TRIM46 Organizes Microtubule Fasciculation in the Axon Initial Segment Journal of Neuroscience

Oligodendrocyte–axon metabolic coupling is mediated by extracellular K - Nature

Oligodendrocyte–axon metabolic coupling is mediated by extracellular K Nature

The Axon Initial Segment: An Updated Viewpoint - Journal of Neuroscience

The Axon Initial Segment: An Updated Viewpoint Journal of Neuroscience

Mechanosensing is critical for axon growth in the developing brain - Nature

Mechanosensing is critical for axon growth in the developing brain Nature

Patterning and axon guidance of cranial motor neurons - Nature

Patterning and axon guidance of cranial motor neurons Nature

In vivo measurement of afferent activity with axon-specific calcium imaging - Nature

In vivo measurement of afferent activity with axon-specific calcium imaging Nature

Mechanisms of axon ensheathment and myelin growth - Nature

Mechanisms of axon ensheathment and myelin growth Nature

Treatment synergy in axon regeneration - Nature

Treatment synergy in axon regeneration Nature

Axon–soma communication in neuronal injury - Nature

Axon–soma communication in neuronal injury Nature

miR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non–Cell-Autonomous Mechanism in ALS - Journal of Neuroscience

miR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non–Cell-Autonomous Mechanism in ALS Journal of Neuroscience

Dendrites Impact the Encoding Capabilities of the Axon - Journal of Neuroscience

Dendrites Impact the Encoding Capabilities of the Axon Journal of Neuroscience

Reassembly of Excitable Domains after CNS Axon Regeneration - Journal of Neuroscience

Reassembly of Excitable Domains after CNS Axon Regeneration Journal of Neuroscience

Neuronal activity biases axon selection for myelination in vivo - Nature

Neuronal activity biases axon selection for myelination in vivo Nature

Axon degeneration mechanisms: commonality amid diversity - Nature

Axon degeneration mechanisms: commonality amid diversity Nature

Ultra-rapid axon-axon ephaptic inhibition of cerebellar Purkinje cells by the pinceau - Nature

Ultra-rapid axon-axon ephaptic inhibition of cerebellar Purkinje cells by the pinceau Nature

Taxol Facilitates Axon Regeneration in the Mature CNS - Journal of Neuroscience

Taxol Facilitates Axon Regeneration in the Mature CNS Journal of Neuroscience

Is action potential threshold lowest in the axon? - Nature

Is action potential threshold lowest in the axon? Nature

Nicotinic control of axon excitability regulates thalamocortical transmission - Nature

Nicotinic control of axon excitability regulates thalamocortical transmission Nature

Glial inhibition of CNS axon regeneration - Nature

Glial inhibition of CNS axon regeneration Nature

Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling - Nature

Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling Nature

Macrophages Promote Axon Regeneration with Concurrent Neurotoxicity - Journal of Neuroscience

Macrophages Promote Axon Regeneration with Concurrent Neurotoxicity Journal of Neuroscience

Localized Sources of Neurotrophins Initiate Axon Collateral Sprouting - Journal of Neuroscience

Localized Sources of Neurotrophins Initiate Axon Collateral Sprouting Journal of Neuroscience

Top Axon Neuroscience Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant